Label: DEXTROSE AND SODIUM CHLORIDE- dextrose monohydrate and sodium chloride injection, solution

  • NDC Code(s): 17271-734-05, 17271-734-06, 17271-734-07
  • Packager: BECTON DICKINSON AND COMPANY
  • Category: HUMAN PRESCRIPTION DRUG LABEL

Drug Label Information

Updated November 7, 2024

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

  • SPL UNCLASSIFIED SECTION
    5% Dextrose and 0.45% Sodium Chloride Injection, USP - Rx only
  • DESCRIPTION
    5% Dextrose and 0.45% Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are large volume parenteral solutions containing 5 grams per 100 mL of Dextrose monohydrate and ...
  • CLINICAL PHARMACOLOGY
    When administered intravenously, these solutions provide a source of water, carbohydrate and electrolytes. Solutions which provide combinations of hypotonic or isotonic concentrations of dextrose ...
  • INDICATIONS AND USAGE
    Intravenous solutions containing dextrose and sodium chloride are indicated for parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride as required by the clinical ...
  • CONTRAINDICATIONS (What is this?)
    None known.
  • WARNINGS
    Solutions containing sodium ions should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency and in clinical states in which there exists edema ...
  • PRECAUTIONS
    Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations and acid-base balance during prolonged parenteral therapy ...
  • ADVERSE REACTIONS
    Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the ...
  • OVERDOSAGE
    In the event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. See WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS.
  • DOSAGE AND ADMINISTRATION
    The dose is dependent upon the age, weight and clinical condition of the patient. As reported in the literature, the dosage and constant infusion rate of intravenous dextrose must be selected ...
  • HOW SUPPLIED
    5% Dextrose and 0.45% Sodium Chloride Injection, USP is supplied in single-dose flexible plastic containers in 250 mL, 500 mL and 1000 mL sizes as follows: Product CodeUnit of ...
  • PRINCIPAL DISPLAY PANEL(What is this?)
    PACKAGE LABEL - PRINCIPAL DISPLAY – Dextrose and Sodium Chloride 250mL Bag Label - freeflex®          NDC 17271-734-05         250 mL - 5% Dextrose and - 0.45% Sodium Chloride - Injection ...
  • PRINCIPAL DISPLAY PANEL
    PACKAGE LABEL - PRINCIPAL DISPLAY – Dextrose and Sodium Chloride 250mL Shipper Label - NDC 17271-734-05           1727173405 - 5% Dextrose and 0.45% Sodium Chloride - Injection, USP - 250 mL x ...
  • PRINCIPAL DISPLAY PANEL
    PACKAGE LABEL - PRINCIPAL DISPLAY – Dextrose and Sodium Chloride 500mL Bag Label - freeflex®          NDC 17271-734-06          500 mL - 5% Dextrose and - 0.45% Sodium Chloride - Injection ...
  • PRINCIPAL DISPLAY PANEL
    PACKAGE LABEL - PRINCIPAL DISPLAY – Dextrose and Sodium Chloride 500mL Shipper Label - NDC 17271-734-06          1727173406 - 5% Dextrose and 0.45% Sodium Chloride - Injection, USP - 500 mL x ...
  • PRINCIPAL DISPLAY PANEL
    PACKAGE LABEL - PRINCIPAL DISPLAY – Dextrose and Sodium Chloride 1,000mL Bag Label - freeflex®          NDC 17271-734-07          1000 mL - 5% Dextrose and - 0.45% Sodium Chloride - Injection ...
  • PRINCIPAL DISPLAY PANEL
    PACKAGE LABEL - PRINCIPAL DISPLAY – Dextrose and Sodium Chloride 1000mL Shipper Label - NDC 17271-734-07          727173407 - 5% Dextrose and 0.45% Sodium Chloride - Injection, USP - 1,000 mL x ...
  • INGREDIENTS AND APPEARANCE
    Product Information